搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Escherichia coli O45:K1 UPF0267 protein yqfB (yqfB) CSB-YP486127EOK
CSB-EP486127EOK
CSB-BP486127EOK
CSB-MP486127EOK
CSB-EP486127EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 UPF0149 protein ygfB (ygfB) CSB-YP486128EOK
CSB-EP486128EOK
CSB-BP486128EOK
CSB-MP486128EOK
CSB-EP486128EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 UPF0301 protein yqgE (yqgE) CSB-YP486129EOK
CSB-EP486129EOK
CSB-BP486129EOK
CSB-MP486129EOK
CSB-EP486129EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Probable RNA 2'-phosphotransferase (kptA) CSB-YP486130EOK
CSB-EP486130EOK
CSB-BP486130EOK
CSB-MP486130EOK
CSB-EP486130EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Membrane-bound lytic murein transglycosylase C (mltC) CSB-YP486131EOK
CSB-EP486131EOK
CSB-BP486131EOK
CSB-MP486131EOK
CSB-EP486131EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Purine nucleoside phosphorylase DeoD-type (deoD) CSB-YP486132EOK
CSB-EP486132EOK
CSB-BP486132EOK
CSB-MP486132EOK
CSB-EP486132EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Chaperone protein DnaJ (dnaJ) CSB-YP486133EOP
CSB-EP486133EOP
CSB-BP486133EOP
CSB-MP486133EOP
CSB-EP486133EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Carnitine operon protein CaiE (caiE) CSB-YP486134EOP
CSB-EP486134EOP
CSB-BP486134EOP
CSB-MP486134EOP
CSB-EP486134EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Glutathione-regulated potassium-efflux system ancillary protein kefF (kefF) CSB-YP486135EOP
CSB-EP486135EOP
CSB-BP486135EOP
CSB-MP486135EOP
CSB-EP486135EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 L-arabinose isomerase (araA) CSB-YP486136EOP
CSB-EP486136EOP
CSB-BP486136EOP
CSB-MP486136EOP
CSB-EP486136EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Ribosomal RNA small subunit methyltransferase H (rsmH) CSB-YP486137EOP
CSB-EP486137EOP
CSB-BP486137EOP
CSB-MP486137EOP
CSB-EP486137EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 UPF0289 protein yacF (yacF) CSB-YP486138EOP
CSB-EP486138EOP
CSB-BP486138EOP
CSB-MP486138EOP
CSB-EP486138EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Sugar fermentation stimulation protein A (sfsA) CSB-YP486139EOP
CSB-EP486139EOP
CSB-BP486139EOP
CSB-MP486139EOP
CSB-EP486139EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Deoxyguanosinetriphosphate triphosphohydrolase (dgt) CSB-YP486140EOP
CSB-EP486140EOP
CSB-BP486140EOP
CSB-MP486140EOP
CSB-EP486140EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase CSB-YP486141EOP
CSB-EP486141EOP
CSB-BP486141EOP
CSB-MP486141EOP
CSB-EP486141EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 UPF0294 protein yafD (yafD) CSB-YP486142EOP
CSB-EP486142EOP
CSB-BP486142EOP
CSB-MP486142EOP
CSB-EP486142EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Anti-adapter protein iraP (iraP) CSB-YP486143EOP
CSB-EP486143EOP
CSB-BP486143EOP
CSB-MP486143EOP
CSB-EP486143EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 S-adenosylmethionine:tRNA ribosyltransferase-isomerase (queA) CSB-YP486144EOP
CSB-EP486144EOP
CSB-BP486144EOP
CSB-MP486144EOP
CSB-EP486144EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Potassium-transporting ATPase B chain (kdpB), partial CSB-YP486145EOP1
CSB-EP486145EOP1
CSB-BP486145EOP1
CSB-MP486145EOP1
CSB-EP486145EOP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Ribonuclease H (rnhA) CSB-YP486146EOP
CSB-EP486146EOP
CSB-BP486146EOP
CSB-MP486146EOP
CSB-EP486146EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>